Logo image of TNON

TENON MEDICAL INC (TNON) Stock Fundamental Analysis

USA - NASDAQ:TNON - US88066N3035 - Common Stock

1.19 USD
-0.03 (-2.46%)
Last: 9/12/2025, 8:21:06 PM
1.18 USD
-0.01 (-0.84%)
After Hours: 9/12/2025, 8:21:06 PM
Fundamental Rating

3

Overall TNON gets a fundamental rating of 3 out of 10. We evaluated TNON against 191 industry peers in the Health Care Equipment & Supplies industry. The financial health of TNON is average, but there are quite some concerns on its profitability. While showing a medium growth rate, TNON is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TNON had negative earnings in the past year.
In the past year TNON has reported a negative cash flow from operations.
TNON had negative earnings in each of the past 5 years.
TNON had a negative operating cash flow in each of the past 5 years.
TNON Yearly Net Income VS EBIT VS OCF VS FCFTNON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

TNON has a worse Return On Assets (-113.87%) than 81.68% of its industry peers.
The Return On Equity of TNON (-188.53%) is worse than 71.73% of its industry peers.
Industry RankSector Rank
ROA -113.87%
ROE -188.53%
ROIC N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TNON Yearly ROA, ROE, ROICTNON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

With a Gross Margin value of 45.44%, TNON is not doing good in the industry: 60.73% of the companies in the same industry are doing better.
TNON's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for TNON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
TNON Yearly Profit, Operating, Gross MarginsTNON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

6

2. Health

2.1 Basic Checks

TNON does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TNON has more shares outstanding
Compared to 5 years ago, TNON has more shares outstanding
There is no outstanding debt for TNON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TNON Yearly Shares OutstandingTNON Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
TNON Yearly Total Debt VS Total AssetsTNON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

TNON has an Altman-Z score of -10.80. This is a bad value and indicates that TNON is not financially healthy and even has some risk of bankruptcy.
TNON has a Altman-Z score of -10.80. This is amonst the worse of the industry: TNON underperforms 81.15% of its industry peers.
TNON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -10.8
ROIC/WACCN/A
WACC8.45%
TNON Yearly LT Debt VS Equity VS FCFTNON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

TNON has a Current Ratio of 3.86. This indicates that TNON is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.86, TNON is in the better half of the industry, outperforming 67.02% of the companies in the same industry.
TNON has a Quick Ratio of 3.59. This indicates that TNON is financially healthy and has no problem in meeting its short term obligations.
TNON has a Quick ratio of 3.59. This is in the better half of the industry: TNON outperforms 70.68% of its industry peers.
Industry RankSector Rank
Current Ratio 3.86
Quick Ratio 3.59
TNON Yearly Current Assets VS Current LiabilitesTNON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

6

3. Growth

3.1 Past

TNON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.63%, which is quite impressive.
The Revenue for TNON has decreased by -12.60% in the past year. This is quite bad
TNON shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 130.83% yearly.
EPS 1Y (TTM)78.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.59%
Revenue 1Y (TTM)-12.6%
Revenue growth 3Y173.6%
Revenue growth 5Y130.83%
Sales Q2Q%-37.4%

3.2 Future

The Earnings Per Share is expected to grow by 14.89% on average over the next years. This is quite good.
The Revenue is expected to grow by 66.32% on average over the next years. This is a very strong growth
EPS Next Y92.39%
EPS Next 2Y40.08%
EPS Next 3Y25.55%
EPS Next 5Y14.89%
Revenue Next Year24.48%
Revenue Next 2Y50.58%
Revenue Next 3Y64.91%
Revenue Next 5Y66.32%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
TNON Yearly Revenue VS EstimatesTNON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M
TNON Yearly EPS VS EstimatesTNON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TNON. In the last year negative earnings were reported.
Also next year TNON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNON Price Earnings VS Forward Price EarningsTNON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNON Per share dataTNON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

A more expensive valuation may be justified as TNON's earnings are expected to grow with 25.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.08%
EPS Next 3Y25.55%

More info and screens

0

5. Dividend

5.1 Amount

TNON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TENON MEDICAL INC

NASDAQ:TNON (9/12/2025, 8:21:06 PM)

After market: 1.18 -0.01 (-0.84%)

1.19

-0.03 (-2.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners2.05%
Inst Owner Change-71.39%
Ins Owners0.27%
Ins Owner Change0%
Market Cap10.57M
Analysts82.5
Price Target6.04 (407.56%)
Short Float %15.63%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.85%
Min EPS beat(2)10.79%
Max EPS beat(2)24.91%
EPS beat(4)4
Avg EPS beat(4)13.41%
Min EPS beat(4)1.96%
Max EPS beat(4)24.91%
EPS beat(8)8
Avg EPS beat(8)21.32%
EPS beat(12)11
Avg EPS beat(12)17.92%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-39.92%
Min Revenue beat(2)-40.64%
Max Revenue beat(2)-39.2%
Revenue beat(4)0
Avg Revenue beat(4)-38.69%
Min Revenue beat(4)-47.97%
Max Revenue beat(4)-26.94%
Revenue beat(8)0
Avg Revenue beat(8)-25.84%
Revenue beat(12)0
Avg Revenue beat(12)-22.46%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.43%
PT rev (3m)1.43%
EPS NQ rev (1m)8.05%
EPS NQ rev (3m)39.85%
EPS NY rev (1m)7.63%
EPS NY rev (3m)32.53%
Revenue NQ rev (1m)7.48%
Revenue NQ rev (3m)2.35%
Revenue NY rev (1m)3.23%
Revenue NY rev (3m)-1.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.59
P/FCF N/A
P/OCF N/A
P/B 1.57
P/tB 1.57
EV/EBITDA N/A
EPS(TTM)-7.54
EYN/A
EPS(NY)-0.92
Fwd EYN/A
FCF(TTM)-1.13
FCFYN/A
OCF(TTM)-1.11
OCFYN/A
SpS0.33
BVpS0.76
TBVpS0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -113.87%
ROE -188.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.44%
FCFM N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
F-Score4
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 45.76%
Cap/Sales 8.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.86
Quick Ratio 3.59
Altman-Z -10.8
F-Score4
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)391.88%
Cap/Depr(5y)N/A
Cap/Sales(3y)47.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.59%
EPS Next Y92.39%
EPS Next 2Y40.08%
EPS Next 3Y25.55%
EPS Next 5Y14.89%
Revenue 1Y (TTM)-12.6%
Revenue growth 3Y173.6%
Revenue growth 5Y130.83%
Sales Q2Q%-37.4%
Revenue Next Year24.48%
Revenue Next 2Y50.58%
Revenue Next 3Y64.91%
Revenue Next 5Y66.32%
EBIT growth 1Y7.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.55%
OCF growth 3YN/A
OCF growth 5YN/A